题名 | Duration of response to androgen-deprivation therapy (ADT) and efficacy of secondary hormone therapy, docetaxel (D), and cabazitaxel (C) in metastatic castration-resistant prostate cancer (mCRPC). |
链接 | http://meetinglibrary.asco.org/content/123640-142 |
求清晰版的poster图片文件,谢谢!
欢迎光临 科研速递论坛 (http://expaper.cn/) | Powered by Discuz! X2.5 |